Sanofi-Aventis Agrees To Cap Insulin At $35 In Settlement With Minnesota

(August 1, 2024, 9:51 AM EDT) -- NEWARK, N.J. — Minnesota Attorney General Keith Ellison and Sanofi-Aventis U.S. LLC told a New Jersey federal court that they have reached a settlement under which the drug manufacturer has agreed to make its insulin products available to consumers in Minnesota for no more than $35 for a monthly subscription....